Release Date:
July 1, 2010 For all you clinicians out there, this is a whopper of a read (pun intended).
Metabolic syndrome is associated with increased propensity for diabetes and cardiovascular disease. Low-grade inflammation is characteristic of metabolic syndrome. C-reactive protein, the best characterized biomarker of inflammation, is also a (independent) predictor of future cardiovascular events.
This comprehensive research review outlines all of the above and creates clear links between cardiovascular disease, metabolic syndrome, blood vessel cell (endothelial cell) function, and immune (monocytes) activity.
Attachment:
